Companies
OpenAI considers slowing the advancement of artificial intelligence
OpenAI is evaluating the possibility of slowing the development of its most advanced AI, coordinating with other labs in the sector.
Latest Regulation news
2 articles
Stem cell therapies are on the rise in the US, but their efficacy and safety are questioned. Clinics offer unapproved treatments that may be dangerous.
OpenAI is evaluating the possibility of slowing the development of its most advanced AI, coordinating with other labs in the sector.